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Amphidinolide H, a Potent Cytotoxic Macrolide,
Covalently Binds on Actin Subdomain 4
and Stabilizes Actin Filament
containment of solid tumors in combination therapy with
other agents. Therefore, proteins involved in cell motility
represent attractive targets for development of new che-
motherapies [3]. Dynamic processes such as cell migra-
tion and division depend on the actin cytoskeleton, a
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teins. It is known that the actin cytoskeleton is substan-2-1 Hirosawa, Wako-shi, Saitama 351-0198
Japan tially modified in transformed cells, and this occurs in
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Several actin inhibitors are reported, and these com-Hokkaido University
Sapporo 060-0812 pounds are largely classified into two types: destabilizer
and stabilizer of actin filaments. Cytochalasins and la-Japan
trunculins are the most famous actin filament destabi-
lizers and are widely used for analyses of cellular func-
tions of actin [4–7]. Mycalolide B [8, 9], swinholide ASummary
[10, 11], aplyronine A [12, 13], and misakinolide A [14,
15] destroy the actin cytoskeleton by severing and/orThe actin-targeting toxins have not only proven to be
sequestering actin. The other class of compounds, actininvaluable tools in studies of actin cytoskeleton struc-
stabilizers, also has been reported. Phalloidin, a mush-ture and function but they also served as a foundation
room toxin, stabilize F-actin by binding at the junctionfor a new class of anticancer drugs. Here, we describe
of two or three actin monomers in the filament and hasthat amphidinolide H (AmpH) targets actin cytoskele-
been widely utilized for analysis of actin dynamics [16,ton. AmpH induced multinucleated cells by disrupting
17]. Jasplakinolide, a cyclodepsipeptide, binds F-actinactin organization in the cells, and the hyperpolymeri-
competitively with phalloidin and induces polymeriza-zation of purified actin into filaments of apparently
tion of monomeric actin as well as stabilizes actin fila-normal morphology in vitro. AmpH covalently binds on
ments [18, 19]. Other stimulators of actin assembly haveactin, and the AmpH binding site is determined as
been reported [20–23], and some of these compoundsTyr200 of actin subdomain 4 by mass spectrometry and
are under investigating for clinical trials.halo assay using the yeast harboring site-directed mu-
It is important to determine the binding site of thesetagenized actins. Time-lapse analyses showed that
drugs to their target proteins for understanding the inhi-AmpH stimulated the formation of small actin-patches,
bition mechanism and development of specific inhibi-followed by F-actin rearrangement into aggregates via
tors. Latrunculin A binds in the interface between subdo-the retraction of actin fibers. These results indicate
mains 2 and 4, and clamps the ATP binding site,that AmpH is a novel actin inhibitor that covalently
suggesting that latrunculin A inhibits actin polymeriza-binds on actin.
tion via inhibiting the nucleotide exchange [24]. Re-
cently, two epoch-making studies on actin binding
Introduction drugs were reported. Klenchin et al. reported that kabi-
ramide C and jaspisamide A, two actin polymerization
Anticancer drug development strategies have tradition- inhibitors, bound a site almost identical to that bound
ally focused on direct inhibition of cancer cell growth. by gelsolin domain 1 [25]. Based on these results and
However, other rate-limiting processes in the progres- the biochemical data of Tanaka et al. [26], Klenchin et
sion of cancers are also promising targets for interven- al. speculated that both compounds mimic the binding
tion. Tumor cell invasion and metastasis, later points of gelsolin family proteins. Oda et al. also reported that
in cancer progression, are inherently thought to be in- dolastatin 11, an F-actin stabilizer, binds in the gap be-
volved in cell motility [1, 2]. Therapeutic agents that tween the two long-pitch F-actin strands, and specu-
potently inhibit invasion and metastasis could be effec- lated that the connection between the strands might be
tive in restraining new tumor formation when earlier ther- a key for the F-actin stabilization [27]. These studies
apy or surgery has failed, or could increase successful clearly showed that the investigation of the drug binding
site is informative for elucidating the inhibitory mech-
anism.*Correspondence: osadah@riken.jp
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networks were not affected (Figure 2H). The actin mor-
phology of AmpH-treated cells resembled that of cells
treated with a potent actin polymerization stimulator,
jasplakinolide [18] (Figure 2J). The effect of AmpH was
also irreversible, at least in a day (data not shown).
AmpH Stimulates Actin Polymerization
and Stabilizes F-Actin In Vitro
The phenotype of the cell treated with AmpH resembled
that with jasplakinolide, actin stabilizer [18, 19]. To eval-Figure 1. Structure of AmpH
uate that AmpH is an F-actin inducer, we examined
actin polymerization by the standard fluorescence assay
(copolymerization of actin and pyrenyl-labeled actin).Amphidinolides are a series of unique cytotoxic mac-
K-actin started polymerization after the apparent lagrolides isolated from dinoflagellates Amphidinium sp.,
time (Figure 3A, open squares). In the presence of jas-which were separated from marine acoel flatworms Am-
plakinolide, actin polymerization started immediatelyphiscolops sp. [28]. Amphidinolide H (AmpH) is a potent
without no apparent lag time (Figure 3A, open circles).cytotoxic 26-membered macrolide possessing unique
This result is consisted with previous report that jasplak-structural features such as an allyl epoxide and vicinally
inolide stimulated nucleation step [19]. On the otherlocated one-carbon branches (Figure 1) [29]. The abso-
hand, there is an apparent lag time in the presence oflute stereochemistry of AmpH has been established on
AmpH; however, net fluorescent intensity increased withthe basis of the X-ray diffraction analysis and synthesis
dose dependently (Figure 3A, closed symbols). Althoughof a degradation product [30]. From the structure-activ-
the effective concentrations of both AmpH and jasplaki-ity relationship of AmpH-type macrolides, it was found
nolide were almost same in situ, higher concentrationsthat the presence of an allyl epoxide, an S-cis-diene
of AmpH were required to promote actin polymerizationmoiety, and the ketone at C-20 was important for the
in vitro. The same results were obtained in the case ofcytotoxicity [31]. Although AmpH shows a potent cyto-
pyrenyl-labeled Mg2-actin (data not shown). We nexttoxicity to several carcinoma cell lines at the picogram
examined the effects of AmpH on depolymerization oflevel, the target molecule is unclear. Here, we describe
Mg2-F-actin (Figure 3B). Depolymerization started im-that the target molecule of AmpH is actin cytoskeleton.
mediately after 1/10 dilution of pyrenyl-labeled Mg2-AmpH is the first compound that binds actin polymer
F-actin into buffer G. AmpH prevented depolymerizationcovalently and its binding site is located on the actin
of F-actin in a dose-dependent manner. The time re-subdomain 4.
quired to achieve stabilization of F-actin was less than
or equal to the time required to mix the sample (5 s).Results
These results clearly showed that AmpH promotes actin
polymerization and stabilizes F-actin.Effects of AmpH on the Mammalian Cells
To confirm that the increase in fluorescence intensityAmpH shows a potent cytotoxicity against murine lym-
reflected actin polymerization, samples were negativelyphoma L1210 and human epidermoid carcinoma KB
stained with uranyl acetate and examined by electroncells with picogram order IC50 values [29]. To clarify the microscopy (Figure 3C). Numerous 9 nm wide filamentseffects of AmpH on the cells, we investigated the effect
were present in the samples with AmpH, and their ap-of AmpH on the cell cycle in exponentially growing rat
pearance was indistinguishable from that of control.normal fibroblast 3Y1 cells. The distribution profile of
cellular DNA contents after 42 hr of 100 nM AmpH treat-
ment was determined by flow cytometry (Figure 2A). AmpH Covalently Binds Actin In Vitro and In Situ
It is known that some bioactive compounds containingFour peaks corresponding to 2C, 4C, 8C, and 16C were
observed in AmpH-treated cells (AmpH; Figure 2A), epoxide bind their target molecules covalently [33–36].
Since the structure-activity relationships showed thatmeaning AmpH induced polyploid cells. By phase con-
trast observation, AmpH-induced polyploid cells were an allyl epoxide is important for the cytotoxicity of AmpH
[31], there is a possibility that AmpH covalently modifieslarger than nontreated cells, and most of the AmpH-
treated cells possessed two or more nuclei (Figures 2B actin via epoxide. To clarify this possibility, we investi-
gated the change of molecular weight of actin afterand 2C). It is known that these phenotypes occur by
cytokinesis inhibition, such as that by treatment with AmpH treatment by MALDI-TOF mass spectrometry
(Figure 4A). The molecular weight of native actin wascytochalasin B, an actin polymerization inhibitor [32].
To determine whether or not AmpH interferes with the determined to be 41,988 (AmpH; Figure 4A), but that
of AmpH-treated actin was 42,524 (AmpH; Figure 4A).functions of the actin cytoskeleton, we observed the
cytoplasmic actin stress fibers by fluorescence micros- The difference, 536, was thought to represent the molec-
ular weight of AmpH (562). This binding is highly specific,copy (Figures 2D–2I). In the control cells, we observed
actin stress fibers running from one edge of the cell to because treatment with a 10 excess molar amount of
AmpH resulted in the mass increase corresponding tothe other (Figure 2D). After 6 hr of treatment with 30 nM
AmpH, the actin stress fibers had completely disap- only one AmpH. To determine the AmpH binding site
on actin, native and AmpH-treated actin were alkylatedpeared, and only a few disorganized aggregates re-
mained in the cells (Figure 2G), but the microtubule and digested with trypsin, and the generated peptides
AmpH Stabilize Actin Filament by Covalent Binding
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Figure 2. Effects of AmpH on 3Y1 Cells
(A) Effects of AmpH on the distribution of DNA content in asynchronous 3Y1 cell culture was analyzed by flow cytometry. Asynchronous 3Y1
cells were treated with 300 nM AmpH for 0 (AmpH) or 42 hr (AmpH).
(B and C) Binucleated cell formation by AmpH. 3Y1 cells were treated with 300 nM AmpH for 0 (B) or 42 hr (C). Binucleated cells were indicated
by red arrows.
(D–I) Effects of AmpH on the actin and tubulin cytoskeletons. 3Y1 cells were treated with 30 nM AmpH for 0 (D–F) or 6 hr (G–I). (D and G)
Actin cytoskeleton stained with rhodamine-phalloidin. (E and H) Tubulin cytoskeletons stained with anti--tubulin antibody. (F and I) Merged
images with actin (red), tubulin (green), and DNA (blue, stained with Hoechst 33258) are shown.
(J) Effect of jasplakinolide on the actin cytoskeleton. 3Y1 cells were treated with 30 nM jasplakinolide for 6 hr.
were analyzed with MALDI-TOF/TOF mass spectrome- Amphidinolide H Covalently Binds on Tyr200
If the interaction between the drug and its cellular targettry. The amino acid sequences of the digested peptides
were deduced based on the molecular masses. The is impaired by mutation, this would lead to a dominant
phenotype specifically resistant to the drug. Becausemass corresponding to peptide Gly199-Arg208 (1130.5
mass) had disappeared, and a single extra mass, 1692.8, actin is a highly conserved protein and AmpH inhibited
the growth of the wild-type yeast strain by inhibiting theappeared in AmpH-treated protein (Figure 4B). This new
fragment mass corresponded to the AmpH-adduct of function of actin (data not shown), we next tested the
AmpH sensitivity of the yeast cells carrying an actinpeptide Gly199-Arg208. These results clearly show that
AmpH covalently binds to the Gly199-Arg208 fragment of mutant. Since allyl epoxide is reactive with hydroxyl
moiety, there are five candidate residues for the AmpHactin. Although we performed a detailed MS/MS analysis
to identify the exact binding site of AmpH, we obtained binding residue on ACT1: Tyr198, Ser199, Ser201,
Thr202, and Thr203. Cells from which the chromosomalthe original peptide mass without AmpH binding as a
main peak. This result suggests that the bond between ACT1 was deleted and which were kept alive by ACT1
on a URA3-based plasmid were transformed with LEU2-AmpH and peptide is readily broken under the MS/MS
condition. based plasmids containing site-directed mutagenized
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function in yeast (Figure 5A). The obtained ACT1 mutant
cells were subjected to a halo assay [37]. Because cells
carrying the wild-type and all of the cells containing the
ACT1 mutants showed growth inhibition against latrun-
culin A, we concluded that these mutations were not
responsible for latrunculin A resistance (data not shown).
Although cells carrying the wild-type and ACT1 mutants,
with the exception of the Tyr198Phe ACT1 mutant, were
sensitive to AmpH, Tyr198Phe ACT1 mutant cells showed
AmpH resistance (Y198F; Figure 5B). This result strongly
suggests that Tyr198 (corresponding to Tyr200 on mam-
malian actin) on actin is involved in the AmpH binding.
F-Actin Aggregation Formed by Retraction
of Preexisted Stress Fiber
It is known that jasplakinolide, which stimulates actin
polymerization, causes the accumulation of F-actin ag-
gregates in cells, as observed in Figure 2J [38]. Bubb
et al. proposed that this phenomenon is caused by for-
mation of multiple actin filament nuclei with fiber propa-
gation limited by the resulting shortage of monomeric
actin in the cells [19]. To examine this model, we investi-
gated the process of the formation of F-actin aggregates
in detail by time-lapse video microscopy with 5 s inter-
vals using GFP--actin-expressing cells. Before AmpH
addition, the dynamic movements of lamellipodia were
observed (Figure 6A, arrow). Within 30 s after addition
of 250 nM AmpH, the movements of lamellipodia had
completely ceased (Figure 6A, arrow), and several small
actin clumps had emerged in the cell (Figures 6A and
6B). Within 10 min after the addition of AmpH, drastic
morphological changes occurred by the retraction of
actin stress fibers, and large actin aggregates were
formed in the cell. These results clearly show that the
large F-actin aggregates are derived from preexisting
stress fibers.
Discussion
AmpH Is a Novel Actin Stabilizer
Anti-actin compounds have the potential to function as
anticancer drugs. In this paper, we report that AmpH, aFigure 3. Effects of AmpH on Actin Polymerization In Vitro
potent cytotoxic compound, targets and stabilizes actin
(A) Effects of AmpH on the copolymerization of actin and pyrenyl-
cytoskeleton. AmpH induced the formation of polyploidlabeled actin. Actin/pyrenyl-labeled actin (4 M) was incubated with
cell containing multiple nuclei (Figures 2A–2C). Such ajasplakinolide (open circle, 300 nM), AmpH (closed squares, 10 M;
phenotype is typical for that of drugs which interfereclosed triangles, 20 M; closed circles 50 M), or without chemicals
(open squares). Polymerization was started by the addition of induc- with the function of actin cytoskeleton. To elucidate that
ing salts (100 mM KCl, 1 mM MgCl2, 1 mM ATP) and drugs solved AmpH interferes with the functions of actin, we observed
in DMSO at time 0 (final 1% DMSO in reaction mixture). the distributions of F-actin by staining with rhodamine-
(B) Effects of AmpH on the depolymerization of actin and pyrenyl-
phalloidin. Although many actin stress fibers were ob-labeled actin. Pyrenyl-labeled actin Mg2-F-actin (4 M) was diluted
served in control fibroblast cells, there were no actinto 0.4 M. After 75 s, AmpH was added. The samples were mixed
stress fibers in the AmpH-treated cells. Instead, thereto give final concentrations of 10M (closed squares), 50M (closed
triangles), 100 M (closed circles), or 0 M (open squares) AmpH. were many irregular aggregates (Figure 2G). These phe-
(C) Electron microscopy of actin polymer formed in the presence notypes resembled that of jasplakinolide, a stimulator
or absence of AmpH. 24,000. for actin polymerization [19, 39] (Figure 2J). As expected,
AmpH stimulated the polymerization of pyrenyl-labeled
actin and stabilized preformed F-actin (Figures 3A andACT1. Cells were then tested for growth on 5-fluororo-
orotic acid (5-FOA). Because the 5-FOA selects against 3B). These results clearly showed that AmpH is a novel
actin stabilizer.the URA3-based ACT1 plasmid, the LEU2-based ACT1
construct was the only source of ACT1 activity in the Are the effects of AmpH on the actin the same with
jasplakinolide? Our data, that jasplakinolide stimulated5-FOA-resistant colonies. All ACT1 mutants comple-
mented act1, suggesting that these ACT1 mutants the pyrenyl-labeled actin polymerization with no obvious
AmpH Stabilize Actin Filament by Covalent Binding
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Figure 4. AmpH Covalently Modified Actin In
Vitro
(A) MALDI-TOF MS analysis of AmpH-treated
actin.
(B) MALDI-TOF/TOF MS analysis of trypsin-
digested actin. 1130.5 mass fragment in the
upper panel is corresponding to 199–208 aa
of -actin. In the lower panel (amphidinolide
H treated), 1130.5 mass fragment was disap-
peared and 1692.8 mass fragment (corre-
sponding to 199208 aa of -actin  AmpH)
was observed.
lag time, is consistent with the previous report that jas- AmpH did not facilitate the nucleation even in the prein-
cubation of G-actin under nonpolymerizing conditionplakinolide augments nucleation (Figure 3A, [19]). In
contrast, there were lag time in the pyrenyl-labeled actin (data not shown). These results strongly suggest that
the effects of AmpH on actin are different from thatpolymerization induced by AmpH, nevertheless the
mass of polymerized actin increased. Furthermore, of jasplakinolide. Since it is suggested that phalloidin,
Figure 5. Yeast act1-Y198F Showed AmpH
Resistance In Situ
(A) Site-directed mutagenized actins support
the viability of the cells lacking wild-type
actin.
(B) The cell harboring Y198F-mutated actin
is resistant against AmpH.
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Figure 6. Time-Lapse Analysis of the Actin Cytoskeleton In Situ
(A) 250 nM AmpH was added at time 0, and collection time(s) of the images of GFP--actin-expressing 3Y1 cells were shown.
(B) 2 magnification of (A).
without a large effect on the rate constant for nucleation, AmpH Covalently Binds to Actin
As expected from the analysis of the structure-activitystabilizes F-actin by decreasing the rate of dissociation
of actin oligomer [40], AmpH might be a phalloidin-type relationships [31], the covalent binding of AmpH to the
target protein, actin, was elucidated by MALDI-TOFcompound. To elucidate the actin stabilization mecha-
nism of AmpH, the quantitative evaluation of nucleation mass spectrometry (Figure 4A). The binding is specific
and only one AmpH binds to one actin protein. Theand elongation rate constants should be investigated.
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binding site of AmpH was determined by MALDI-TOF gesting that the supply of free G-actin, required for the
aggregate formation, is limited by the same mechanismmass spectrometry as the fragment Gly199-Arg208,
which participates in a loop in the actin subdomain 4 in lamellipodia.
Within the next 10 min, drastic morphological changes(Figure 4B). This region is important for regulation of
actin dynamics; for example, actin-fragmin kinase phos- occurred by the retraction of actin stress fibers, and
large actin aggregates were formed in the cell. Since thephorylates at residues Thr203 and Thr202, and abolishes
the nucleating activity in Physarum polycephalum [41]. same results were obtained in the case of jasplakinolide
(data not shown), this is the common feature of actin-Furthermore, the AmpH binding region is close to the
actin-actin contact between subdomain 4 of one subunit stabilizing drugs. However, these results are not consis-
tent with the previous model [19]. In the previous model,and subdomain 1 of the diagonally located subunit in
the F-actin model refined by Tirion and coworkers [42]. the significant aggregate-formation starts only after the
remodeling of stress fibers sufficiently augments theIt is widely believed that the diagonal contact is relatively
weak in the F-actin structure. Therefore, strengthening G-actin pool to allow for drug-induced filament nucle-
ation. However, F-actin aggregates were formed by thethe diagonal contact, either directly by binding of the
drug or through the conformational change induced by retraction of preexisting stress fibers in the presence of
AmpH and jasplakinolide. These results suggest that thedrug binding, should induce F-actin stabilization.
We also determined that the Tyr200 on actin subdo- new nucleated filaments might not be required for the
formation of F-actin aggregates, although small actinmain 4 is key residue for AmpH-covalent binding. Since
hydroxyl moiety is not highly reactive nucleophile com- clumps were also formed by drug treatment. Further
investigation will be needed to determine how AmpHpared to sulfhydryl moiety, there is a possibility that
Tyr200 is in a special environment making it more reac- initiates the retraction of preexisting stress fibers.
tive. Supporting this possibility, AmpH did not bind to
the peptide of the AmpH binding subdomain (data not Significance
shown). Furthermore, AmpH did not facilitate the nucle-
ation (Figure 3A) but quickly stabilized F-actin (Figure The actin-targeting toxins have not only proven to be
3B). These results suggest that AmpH binding pocket invaluable tools in studies of actin cytoskeleton struc-
is formed when actin polymerizes, and that AmpH could ture and function but they also served as a foundation
not bind to monomeric actin. for a new class of anticancer drugs. In this paper,
we found that AmpH, a potent cytotoxic macrolide,
targets actin cytoskeleton and stabilizes F-actin. Dif-F-Actin Aggregation Formed by Retraction
ferent from previously reported F-actin stabilizers,of Preexisted Stress Fiber
AmpH covalently binds on actin. We determined that
It is known that the drug, which stimulates actin poly-
AmpH binding site is Tyr200 of actin subdomain 4 by
merization, cause the accumulation of F-actin aggre-
mass spectrometry and the systematic mutagensis of
gates in the cells as observed in Figures 2G and 2J. Bubb
yeast actin. This residue is close to the actin-actin
et al. [19] proposed that this phenomenon is caused by
contact between subdomain 4 of one subunit and sub-
formation of multiple actin filament nuclei in the drug-
domain 1 of the diagonally located subunit in the
treated cells, with fiber propagation limited by the re-
F-actin. As the other F-actin stabilizers, for example,
sulting shortage of monomeric actin in the cells. To
phalloidin, jasplakinolide, and dolastatin 11, also lo-
examine this model, we investigated the process of the
cate the same actin-actin contact site, strengthening
formation of F-actin aggregates in detail by the time-
the diagonal contact might be a common feature of
lapse observation using GFP--actin-expressing cells.
F-actin stabilizers. We also showed that AmpH stimu-
AmpH inhibited the movement of lamellipodia com-
lated F-actin rearrangement into aggregates via the
pletely and induced the formation of several small actin
retraction of actin fibers. AmpH should be a useful
clumps in a minute (Figure 6). Inhibition of the dynamic
tool to investigate the regulation of actin stress fiber.
movement of lamellipodia indicates that AmpH stabi-
lizes the dense network of actin filaments without either
Experimental Procedurespolymerization or depolymerization of actin. The inhibi-
tion of actin polymerization might be due to the depriva- Cell Culture, Flow Cytometry,
tion of free G-actin via inhibition of the treadmilling of and Immunofluorescence Procedure
3Y1 cells (rat normal fibroblasts) and HT1080 cells (human fibrosar-lamellipodia. Small actin clumps might be short actin
coma) were cultured in Dulbecco’s modified Eagle’s medium sup-filaments, and their formation was observed not only in
plemented with 10% fetal calf serum in a humidified atmospherethe cells treated with AmpH but also in those treated
containing 5% CO2. The flow cytometry and immunofluorescencewith jasplakinolide (data not shown). These results
procedures were performed as described previously [43]. GFP-
would seem to be paradoxical, since the in vitro activity fused -actin was a gift from Prof. Gerard Marriott (University of
of AmpH is different from that of jasplakinolide (Figure Illinois, Champaign-Urbana, IL) and transfected into exponentially
growing 3Y1 cells with Effectene Transfection Reagent (Qiagen,2A). Unlike jasplakinolide, AmpH shows no apparent
Tokyo, Japan), and GFP signals were observed with a DeltaVisionnucleation activity in vitro. One possibility is that AmpH
system (Applied Precision, Issaquah, WA) including an Olympusexerts its nucleation activity in vivo via regulation of the
IX70 inverted microscope (Olympus, Tokyo, Japan), with a 60 (nu-activity of actin binding proteins, such as the Arp2/3
merical aperture, 1.4) objective lens and an Olympus MI-IBC stage-
complex. Alternatively, AmpH only stabilizes short actin heating device (Olympus). Images were captured with a cooled,
filaments, which are formed by spontaneous nucleation. charge-coupled-device camera from Princeton Instruments (Tren-
ton, NJ). 180–360 optical images were captured at 5 s intervals,These small clumps did not form large aggregates, sug-
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and out-of-focus light was removed by iterative deconvolution on cell suspension was poured onto the surface of a YPDA plate. 10 l
of LatA (3 g/ml), AmpH (100 M), or DMSO alone was pipetteda Silicon Graphics (Mountain View, CA) Iris workstation.
onto the center of thin, sterile paper disks (6 mm diameter; Advantec
MFS, Inc., Tokyo, Japan). The disks were then placed on top of theActin Purification, Polymerization/Depolymerization Assay,
agar. The plate was inverted and left at 30C for 24–48 hr, until halosand Electron Microscopy
were clearly visible.Actin was prepared from the acetone powder of rabbit back muscle,
according to the method of Spudich and Watt [44]. For centrifugal
assay, various concentrations of drug in 1 l of DMSO were added Acknowledgments
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